Mon, December 19, 2022

Joseph Pantginis Maintained (ATXS) at Strong Buy with Increased Target to $20 on, Dec 19th, 2022

Joseph Pantginis of HC Wainwright & Co., Maintained "Astria Therapeutics, Inc." (ATXS) at Strong Buy with Increased Target from $13 to $20 on, Dec 19th, 2022.

Joseph, nor any peers, have made any analyst calls on ATXS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30